|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Intellia Therapeutics (NASDAQ: NTLA) through any online brokerage.
The latest price target for Intellia Therapeutics (NASDAQ: NTLA) was reported by Oppenheimer on June 29, 2021. The analyst firm set a price target for 125.00 expecting NTLA to fall to within 12 months (a possible -8.20% downside). 21 analyst firms have reported ratings in the last year.
The stock price for Intellia Therapeutics (NASDAQ: NTLA) is $136.17 last updated Today at 8:00:02 PM.
There are no upcoming dividends for Intellia Therapeutics.
There is no upcoming split for Intellia Therapeutics.
Intellia Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.